Special Issue "Novel Structural Studies of Coronavirus Proteins"
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 6481
Interests: chemistry; crystallography; time resolved diffraction; free electron lasers; synchrotron radiation
Interests: serial crystallography; time-resolved dynamics; metalloenzymes; crystallography methods; room temperature crystallography
Interests: macromolecular serial crystallography at synchrotrons radiation sources and X-ray free electron lasers (XFELs); structural biology; protein dynamics; drug discovery; development of protein micro-crystallization and sample delivery methods for serial crystallography
Special Issues, Collections and Topics in MDPI journals
Special Issue in Crystals: Macromolecular Serial Crystallography (Volume II)
During the past year, the COVID-19 pandemic’s severity refocused many scientific efforts to research related to SARS-CoV-2. Large facilities worldwide, such as synchrotrons and XFELs, dedicated overwhelming time and energy to this exceptional and ongoing story. The focused timeline and scope of COVID-19 related research will certainly be remembered as an historic effort across many scientific fields, including that of structural biology. Structural studies have shown to be critical in identifying important features for COVID-19 research, and highlighting these studies is a particular motivation for this Special Issue of Crystals. We hope that this serves as a celebration of the contributions from crystallographers worldwide to COVID-19-related research.
Thus, the main goal of this Special Issue, “Novel Structural Studies of Coronavirus Proteins”, will be to gather both research and review articles from experts in the field (chemists, biologists, physicists, and structural biologists), with the ultimate goal of creating an international platform that provides with rich and reference information on the latest advances and exciting discoveries in the field of X-ray crystallography at synchrotrons and XFELs towards understanding the functioning of SARS-CoV-2 to advance develop new drug treatments and vaccines against the ongoing COVID-19 pandemic.
Prof. Dr. Marc Messerschmidt
Dr. Jeney Wierman
Dr. José Manuel Martín-García
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Crystals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Novel structures
- Time resolved structures
- X-ray crystallography
- Structure-based drug discovery
- X-ray free electron lasers